drug

Natalizumab

MeSH D000069442
as of 2026-07-01
at a glance
small molecule
Pre-approval / investigational in the US
Developed by King's College London
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)

Trials

1
Inflammatory Response In Schizophrenia
NCT03093064Phase 1Completed

KOLs & investigators

1
Oliver D HowesKOL score 29

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
indication
indication
indication
KOL
Oliver D Howes
KOL score 29
person